Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2020 16:32 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum

LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to...
November 04, 2020 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Third Quarter 2020 Financial Results

LEXINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the third...
October 19, 2020 16:42 ET | Source: T2 Biosystems, Inc.

Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member

LEXINGTON, Mass. and SAN DIEGO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, and Sepsis Alliance, the first and...
October 14, 2020 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020

LEXINGTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial...
September 30, 2020 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million

LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that the Biomedical Advanced...
September 16, 2020 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Participate in Sepsis Alliance Summit

LEXINGTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it is participating in the...
September 04, 2020 07:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year

LEXINGTON, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Centers for...
August 31, 2020 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test

LEXINGTON, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Food and Drug...
August 11, 2020 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Second Quarter 2020 Financial Results

LEXINGTON, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the second...
August 05, 2020 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split

LEXINGTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that its Board of Directors has...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right